TrialThe European respiratory journal2024

Titration of anti-IL-5 biologics in severe asthma: an open-label randomised controlled trial (the OPTIMAL study).

Marianne Baastrup Soendergaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.